rs1800450 — MBL2 Gly54Asp (variant B)

MBL2 Gly54Asp — When the Innate Immune Net Has Holes

Mannose-binding lectin (MBL)¹¹ Mannose-binding lectin (MBL)
a calcium-dependent (C-type) lectin synthesized in the liver and secreted into serum, where it circulates as oligomers recognizing carbohydrate patterns on pathogen surfaces is one of the body's most ancient front-line defenses. Before antibodies ever form, MBL patrols the bloodstream, binding to mannose and N-acetylglucosamine patterns on bacteria, viruses, fungi, and parasites — patterns that are common on microbes but absent from mammalian cells. Once bound, MBL triggers the lectin complement pathway²² lectin complement pathway
one of three complement activation routes; the others are classical (antibody-triggered) and alternative (spontaneous), producing opsonins that coat pathogens for phagocyte clearance and directly punching holes in microbial membranes through the membrane attack complex.

The Gly54Asp variant — one of three exon 1 mutations collectively called the "O allele" — is present in roughly 14% of Europeans as an allele frequency³³ 14% of Europeans as an allele frequency, making it one of the most common immunodeficiency-associated variants in humans. Heterozygous carriers have substantially lower serum MBL than wild-type individuals; homozygous carriers may have virtually undetectable circulating MBL.

The Mechanism

The Gly54Asp substitution occurs in the fifth collagen-like repeat of the MBL subunit. Glycine residues at every third position of a collagen triple helix are structurally mandatory⁴⁴ Glycine residues at every third position of a collagen triple helix are structurally mandatory
replacing glycine with any larger amino acid distorts the helix, preventing proper strand winding. The resulting structurally aberrant subunits fail to oligomerize correctly in the endoplasmic reticulum, and misfolded oligomers are degraded or retained by hepatocytes rather than secreted. Even when some protein reaches the circulation, it has reduced complement-activating activity because higher-order oligomers (hexamers, pentamers) are required to simultaneously engage multiple MASP proteases⁵⁵ MASP proteases
MBL-associated serine proteases MASP-1 and MASP-2, which cleave C4 and C2 to form C3 convertase. The result is a leaky complement net that fails to efficiently opsonize or lyse pathogens before adaptive immunity can mount a response — a critical gap early in infection.

The Evidence

The clinical consequences of MBL deficiency depend heavily on immune context. Healthy adults with MBL deficiency are often asymptomatic, because T-cell and antibody-mediated immunity compensate. The risks emerge when these backup systems are stressed.

A 2019 systematic review and meta-analysis covering 2,504 patients and 4,749 controls⁶⁶ A 2019 systematic review and meta-analysis covering 2,504 patients and 4,749 controls
Published in BMC Medical Genomics found that homozygosity for any MBL2 structural variant (B, C, or D allele) was significantly associated with susceptibility to invasive pneumococcal disease (OR 1.67, 95% CI 1.04–2.69). A companion study demonstrated that low MBL serum levels independently predict mortality in pneumococcal sepsis⁷⁷ low MBL serum levels independently predict mortality in pneumococcal sepsis
after adjusting for bacteremia and comorbidities, with levels below 0.5 μg/mL associated with worse outcomes.

For respiratory infections more broadly, a comprehensive review concluded that MBL deficiency predisposes to severe respiratory tract infection⁸⁸ a comprehensive review concluded that MBL deficiency predisposes to severe respiratory tract infection
including community-acquired pneumonia with increased ICU admission and 90-day mortality. The risk is sharpest for infections caused by encapsulated bacteria (such as S. pneumoniae, H. influenzae, N. meningitidis), yeasts, and respiratory viruses — all of which present carbohydrate targets for MBL.

The immunosuppressed setting is where MBL deficiency is most clinically dangerous. A meta-analysis of 11 transplant studies (1,858 patients)⁹⁹ A meta-analysis of 11 transplant studies (1,858 patients) found any MBL-deficient haplotype was significantly associated with post-transplant bacterial and fungal infections. In liver transplantation specifically, donor MBL2 deficiency conferred IRR 2.4 for pneumonia and IRR 5.62 for septic shock¹⁰¹⁰ donor MBL2 deficiency conferred IRR 2.4 for pneumonia and IRR 5.62 for septic shock. In stem cell transplantation, MBL2 coding mutations were associated with OR 4.1 for major infection in donors¹¹¹¹ MBL2 coding mutations were associated with OR 4.1 for major infection in donors.

In the context of COVID-19, a study of 264 patients¹²¹² a study of 264 patients found that B allele carriers had approximately 2-fold increased risk for hospitalization and pneumonia development, consistent with MBL's role in recognizing the spike protein carbohydrates of SARS-CoV-2.

MBL deficiency also has documented associations with Staphylococcus aureus, Candida albicans, Aspergillus fumigatus, and Plasmodium falciparum infections, as well as RSV, herpes simplex, hepatitis B and C, and HIV — reflecting the broad pathogen coverage MBL provides.

Practical Implications

MBL deficiency does not mean you will be sick constantly. Most deficient adults are healthy. The vulnerability surfaces during windows of immune challenge: new pathogens before antibodies form, immunosuppressive medical treatments, and situations with high pathogen loads. Vaccination is the most direct way to pre-arm your antibody system, closing the gap that MBL deficiency leaves open. Prioritizing pneumococcal, meningococcal, and influenza vaccines ensures that even when innate complement defenses are weak, trained adaptive immunity is ready.

MBL is also one of the first proteins to recognize and clear the body of bacteria that leak from a dysbiotic gut¹³¹³ dysbiotic gut
a microbiome shifted toward pathogenic species, making gut barrier integrity — supported by prebiotic fiber — an underappreciated indirect protection for MBL-deficient individuals.

Interactions

The three exon 1 structural variants — rs1800450 (B allele, codon 54), rs1800451 (C allele, codon 57, more common in sub-Saharan Africans), and rs5030737 (D allele, codon 52, least common) — all produce the O allele haplotype and are classified as a group because they all impair oligomerization. A person carrying one B allele on one chromosome and one C allele on the other is functionally equivalent to a BB homozygote for MBL deficiency purposes.

The MBL2 promoter variant rs7096206 (Y-221X) modulates how much MBL is transcribed; a combined deficient exon 1 genotype (O/O) plus a low-producer promoter haplotype produces the lowest possible MBL levels. The compound genotype O/O with low promoter activity is most strongly linked to clinically significant infections and the severest COVID-19 outcomes.